HERBAL HEADACHE RELIEF DIN 02231640
Status: Cancelled Post Market
Holder: WAMPOLE BRANDS, A DIVISION OF PANGEO PHARMA (CANADA) INC.
Molecule: WILLOW BARK
Health Canada record
| Active ingredient(s) | WILLOW BARK 300 MG; FILIPENDULA ULMARIA 200 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | |
| Original market date | 05-Nov-1998 |
| Current status date | 29-Jul-2002 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing WILLOW BARK
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02072610 | DR. MILLER'S FORMULA NO. 1 | LITE & RITE INC. | Tablet | WILLOW BARK 280 MG; EPHEDRA 280 MG | Cancelled Post Market |
| 02240354 | ETHICAL HERBALS NATURAL PAIN RELIEVER | ASHBURY RESEARCH CORPORATION | Tablet | WILLOW BARK 500 MG | Cancelled Pre Market |